Supreme Court: Uncrystallized Contractual Damages Not an Operational Debt under Section 9 IBC || Supreme Court: Interest Accrued in Suspense Account After NPA Classification is Recoverable as Debt || Supreme Court: S.69 GST Arrest Order with “Reasons to Believe” Must Precede Arrest || Supreme Court: Winding-Up Proceedings Period Cannot be Excluded under Section 14 Limitation Act || Supreme Court: Separate Appeals Unnecessary Against Common Judgment on Suit and Counterclaim || Supreme Court: Unsuccessful Party Can Seek Post-Award Section 9 Relief in Exceptional Cases || Delhi HC Rejects Black Money Act Challenge, Imposes Rs. 60,000 Costs over Prosecution Avoidance || Delhi HC Affirms Teacher's POCSO Conviction, Urges Schools to Encourage Children to Speak Up || Kerala HC: NGO Funding Peaceful Protests Can't Justify FCRA Renewal Denial || Delhi HC: Courts Cannot Judge Sufficiency of Material For Issuing Look Out Circular

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :